The significance of myelosuppression during therapy with imatinib mesylate in patients with chronic myelogenous leukemia in chronic phase-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The significance of myelosuppression during therapy with imatinib mesylate in patients with chronic myelogenous leukemia in chronic phase

Published:2003 Issue:1 Volume:100 Page:116-121
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Sneed Thomas B.,Kantarjian Hagop M.,Talpaz Moshe,O'Brien Susan,Rios Mary Beth,Bekele B. Nebiyou,Zhou Xian,Resta Debra,Wierda William,Faderl Stefan,Giles Francis,Cortes Jorge E.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference22 articles.

1. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

2. The Biology of Chronic Myeloid Leukemia

3. Induction of Chronic Myelogenous Leukemia in Mice by the P210 bcr/abl Gene of the Philadelphia Chromosome

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imatinib-Induced Bone Marrow Aplasia in Chronic Myelogenous Leukemia;Cureus;2024-05-27

2. Deep learning-assisted smartphone-based quantitative microscopy for label-free peripheral blood smear analysis;Biomedical Optics Express;2024-03-27

3. Setting up a network of comprehensive care for patients with chronic myeloid leukemia: Lessons learned from Tanzania;Seminars in Hematology;2023-09

4. The efficacy and safety of eltrombopag in treating TKI-induced thrombocytopenia in patients with chronic myeloid leukemia;Hematology;2023-08-22

5. Bone Biopsy Confirmed Imatinib-Induced Bone Marrow Necrosis in Patient with Gastrointestinal Tumor: A Case Report;Soonchunhyang Medical Science;2023-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP